Merck KGaA (FRA:MRK)
114.70
-2.30 (-1.97%)
At close: May 16, 2025, 10:00 PM CET
Merck KGaA Revenue
Merck KGaA had revenue of 5.28B EUR in the quarter ending March 31, 2025, with 3.13% growth. This brings the company's revenue in the last twelve months to 21.32B, up 2.38% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.32B
Revenue Growth
+2.38%
P/S Ratio
2.34
Revenue / Employee
340.49K
Employees
59,020
Market Cap
49.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 107.35B |
Rheinmetall AG | 10.48B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Siemens Energy AG | 37.44B |
Siemens Healthineers AG | 23.14B |
Merck KGaA News
- 3 days ago - Merck KGaA 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 3 days ago - Merck KGaA (MKGAF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Merck KGaA Shares Slide After Outlook Cut on Tariff, Currency Risks - The Wall Street Journal
- 3 days ago - Merck KGaA Non-GAAP EPS of €2.12, revenue of €5.28B; updates FY25 outlook - Seeking Alpha
- 3 days ago - Merck KGaA strikes more cautious tone on 2025 adj profit - Reuters
- 4 days ago - Germany's Merck drops China surcharge on orders after US-China tariff deal - Reuters
- 19 days ago - SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO - Seeking Alpha
- 20 days ago - SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating SpringWorks Therapeutics, Inc. Buyout - Wallstreet:Online